On September 2, 2026 UroGen Pharma Ltd. (Nasdaq: URGN), a biotech company dedicated to developing and commercializing innovative solutions that treat urothelial and specialty cancers, reported that it will participate in the following investor conferences in September.

Schedule your 30 min Free 1stOncology Demo!
Discover why more than 1,500 members use 1stOncology™ to excel in:

Early/Late Stage Pipeline Development - Target Scouting - Clinical Biomarkers - Indication Selection & Expansion - BD&L Contacts - Conference Reports - Combinatorial Drug Settings - Companion Diagnostics - Drug Repositioning - First-in-class Analysis - Competitive Analysis - Deals & Licensing

                  Schedule Your 30 min Free Demo!

Wells Fargo 21st Annual Healthcare Conference

Date / Time: September 9th, at 3:00 PM ET
Format: Fireside Chat
Location: Boston, MA
Webcast Link: Here

Cantor Global Healthcare Conference 2026

Date / Time: September 10th, at 2:10 PM ET
Format: Fireside Chat
Location: New York, NY
Webcast Link: Here

H.C. Wainwright 28th Annual Global Investment Conference

Date / Time: September 15th, at 9:00 AM ET
Format: Fireside Chat
Location: New York, NY
Webcast Link: Here

The webcasts from the conference will also be available on UroGen’s Investor Relations website. A replay will be available for approximately 30 days.

(Press release, UroGen Pharma, SEP 2, 2026, View Source [SID1234670543])